WASHINGTON — American Red Cross blood processing centers have repeatedly failed federal inspections over the last 15 years and continue to have problems that present a "potential for harm" to patients, federal officials said Friday.

"The Red Cross (blood operation) is not in compliance with the current laws and regulations," said Dr. Jay S. Epstein of the Food and Drug Administration. "The problems are serious because of the potential for harm" to patients receiving the blood.

Documents filed by the FDA in the U.S. District Court in Washington said the Red Cross has "a longstanding and ongoing failure to comply with good manufacturing practice" standards in collecting, processing and distributing blood used in medical procedures.

The FDA said the Red Cross "has not been in compliance with the CGMP provisions . . . since at least 1985," and that increasingly tough actions by the FDA have failed to correct the problems.

A top Red Cross official, who would speak only on background and would not agree to be identified, said that the blood supplied by the Red Cross "is the safest in the world," but she admitted that there are serious problems that need to be corrected.

"We are not releasing dangerous blood, but there have been near misses," said the official. "These are red flags and we are jumping on them."

The FDA, in its court filings, said the Red Cross failed FDA inspections in 1985. After repeated notifications of noncompliance, the Red Cross in 1988 entered into an agreement with the FDA to follow a plan to meet agency standards.

The problems continued and the FDA sent three notices threatening to revoke establishment licenses. Eventually the license of one Red Cross center was revoked.

"When even these measures did not spur (the Red Cross) to meaningful action, FDA negotiated" a 1993 court decree that required better controls and a quality assurance program, the court papers said. Since 1993, the FDA said, it has sent 10 letters warning the Red Cross of noncompliance with blood center regulations.

An FDA inspection last July found 25 violations in an Atlanta Red Cross center. A similar inspection of the Red Cross headquarters in Washington found 63 violations.

The violations included an improper release of blood products that tested positive for the cytomegalovirus and failure to follow procedures in a second HIV test of blood that had been rejected because it tested positive for the AIDS virus in an initial test. The HIV-suspected blood was never distributed and the cytomegalovirus-positive blood was not used by patients who could be harmed, a Red Cross official said.

The "current violations are of deep concern to FDA because of the impact they may have on the safety of the nation's blood supply," said the FDA court filing.

Epstein said the FDA officials have been in discussion with Red Cross officials about possible fines to force the Red Cross to comply.

Such fines, said Epstein, "are an appropriate step to provide increased incentives to bring the Red Cross into compliance."

Following the discussion, the Red Cross filed papers in the District Court to block the fines and ask that the court order mediation of the FDA compliance enforcement efforts. In a response, the FDA told the court that it "does not believe mediation would be productive."

The increasingly severe actions of the FDA came to light after Dr. Sidney M. Wolfe, director of Public Citizen's Health Research Group, released copies of a letter he sent to Dr. Jane Henney, commissioner of FDA, asking that the agency "stop playing dangerous, cooperative, polite games with the (Red Cross) and ask that the organization be held in contempt of court" for not complying with the 1993 consent decree.

"Unless the FDA exercises this legal responsibility, there is little evidence that the (Red Cross) will come into compliance with the terms of the (court decree) or with U.S. laws and regulations concerning blood and blood products," Wolfe said in a statement.

The Red Cross official said that Dr. Bernadine Healy, who became the American Red Cross president last year, was not aware of the problems when she took the job. Since then, the high official said, Healy has taken out more than $300 million in loans to build and equip laboratories and to improve the management of the blood supply system.

The official said one blood processing center, in Puerto Rico, has been closed and 50 other centers are being upgraded to comply with FDA regulations.

View Comments

Healy, the official said, has reviewed the Red Cross blood system and has seen problems that "are very disturbing, but we have not seen anything that would harm a patient."

The Red Cross collects, processes and distributes about 6.5 million units of blood annually, about half of the nation's medical blood supply.


On the Net: American Red Cross site: www.redcross.org

FDA site: www.fda.gov

Join the Conversation
Looking for comments?
Find comments in their new home! Click the buttons at the top or within the article to view them — or use the button below for quick access.